Please provide your email address to receive an email when new articles are posted on . Relugolix combination therapy resulted in reduced heavy menstrual bleeding for 82.9% of Black women with uterine ...
Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and ...
Seven oral and poster presentationspresented at the American Society for Reproductive Medicine (ASRM) 2020 Virtual Congress Oral presentation on efficacy and safety data from Phase 3 SPIRIT program ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Ursula A.
The double-blind, placebo-controlled phase 3 study included 229 women who completed the LIBERTY long-term extension study. Positive results were announced from the LIBERTY randomized withdrawal study ...
Rivaroxaban may increase the risk of severe abnormal uterine bleeding compared with other direct oral anticoagulants (DOACs) or warfarin, according to the findings of a retrospective study recently ...
Please provide your email address to receive an email when new articles are posted on . Once-daily treatment with a combination of relugolix, estradiol and norethindrone acetate significantly reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback